In ZR-75-1 cells assessed by qRT-PCR, CAY10505 reversed the miR-1976 inhibitor-induced increase in PIK3CG expression. In primary cultured cortical neurons, CAY10505 pretreatment partially reduced baicalein-induced Akt phosphorylation. Among HBE cells challenged with CSE, GPT2 mRNA expression was significantly lower with CAY10505. The study measuring PIK3CG, AKT, and p-AKT by western blot also reported that CAY10505 reversed the miR-1976 inhibitor-induced increase in PIK3CG mRNA and protein levels in ZR-75-1 cells. [1,2,3]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
PIK3CG mRNA expression following inhibitor treatment
Cell-based study · ZR-75-1 cells [1]
In ZR-75-1 cells, the miR-1976 inhibitor increased PIK3CG mRNA and protein levels, and CAY10505 reversed this effect. PIK3CG mRNA expression was measured by qRT-PCR.
Literature-Reported Treatment Conditions
- Co-treatment
- Other interventions in this design: miR-1976 inhibitor. Compound effect isolated by the comparison: miR-1976 inhibitor increased the mRNA and protein level of PIK3CG in ZR-75-1 cells, and this effect was reversed by CAY10505.
- Reported limits
- Not stated in the sentences used: dose, route, schedule, vehicle.
Methods and source locations
Compound reported in the paper: CAY10505
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Overexpression of PIK3CG accounted for function of miR-1976 (S134); Fig. 6 legend (S168)
The mRNA expression of PIK3CG was measured by qRT-PCR.: The mRNA expression of PIK3CG was measured by qRT-PCR.; comparator: miR-1976 inhibitor — Results > Overexpression of PIK3CG accounted for function of miR-1976 (S134); Fig. 6 legend (S168)
Partial Reduction of Baicalein-Induced Akt Phosphorylation in Cortical Neurons
Cell-based study · primary cultured cortical neurons [2]
In primary cultured cortical neurons, the tested compound at 200 nM with 1 h pretreatment partially reduced baicalein-induced Akt phosphorylation compared with the BA-treated group, as assessed by Western blotting of pAkt and Akt.
Literature-Reported Treatment Conditions
- Treatment concentration
- 200 nM
- Exposure duration
- 1 h pretreatment; 30 min after the BA treatment
- Co-treatment
- Other interventions in this design: BA 3.5 μM. Compound effect isolated by the comparison: with or without 1 h pretreatment.
- Reported limits
- Not stated in the sentences used: route, vehicle.
Methods and source locations
Compound reported in the paper: CAY10505
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Baicalein activates HIF1α to increase Epo and VEGF expression in cortical neurons (S78); Results > Baicalein activates Epo and VEGF gene transcription via class I PI3K/Akt/HIF-1α signaling pathway in cortical neurons (S97); Figure 3 legend (S155, S156, S159)
Western blotting of pAkt and Akt: Western blotting of pAkt and Akt; comparator: BA-treated group — Results > Baicalein activates Epo and VEGF gene transcription via class I PI3K/Akt/HIF-1α signaling pathway in cortical neurons (S97); Figure 3 legend (S156)
Lower GPT2 mRNA Expression in CSE-Challenged HBE Cells
Cell-based study · HBE cells [3]
In HBE cells challenged with CSE, treatment with the tested compound was associated with significantly lower GPT2 mRNA expression compared with cells challenged with CSE.
Literature-Reported Treatment Conditions
- Co-treatment
- Other interventions in this design: CSE. Compound effect isolated by the comparison: When compared amongst cells challenged with CSE.
- Reported limits
- Not stated in the sentences used: dose, route, schedule, vehicle.
Methods and source locations
Compound reported in the paper: CAY10505
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
RESULTS > Interactions between target genes and PI3K signalling pathway (S187, S189); FIGURE 8 legend (S270)
mRNA expression of GPT2: mRNA expression of GPT2; comparator: cells challenged with CSE — RESULTS > Interactions between target genes and PI3K signalling pathway (S189); FIGURE 8 legend (S270)
Protein expression following inhibitor treatment
Cell-based study · ZR-75-1 cells [1]
In ZR-75-1 cells, the miR-1976 inhibitor increased PIK3CG mRNA and protein levels, and CAY10505 reversed this effect. Western blotting measured PIK3CG, AKT, and p-AKT protein expression.
Literature-Reported Treatment Conditions
- Co-treatment
- Other interventions in this design: miR-1976 inhibitor. Compound effect isolated by the comparison: miR-1976 inhibitor increased the mRNA and protein level of PIK3CG in ZR-75-1 cells, and this effect was reversed by CAY10505.
- Reported limits
- Not stated in the sentences used: dose, route, schedule, vehicle.
Methods and source locations
Compound reported in the paper: CAY10505
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
Results > Overexpression of PIK3CG accounted for function of miR-1976 (S134); Fig. 6 legend (S168)
The protein expression levels of PIK3CG, AKT, and p-AKT were measured by western blot.: The protein expression levels of PIK3CG, AKT, and p-AKT were measured by western blot.; comparator: miR-1976 inhibitor — Results > Overexpression of PIK3CG accounted for function of miR-1976 (S134); Fig. 6 legend (S168)